Literature DB >> 16310477

The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study.

Cécile Delcourt1, Annie Lacroux, Isabelle Carrière.   

Abstract

PURPOSE: To assess the 3-year incidence of age-related macular degeneration (AMD) in a French population.
DESIGN: The "Pathologies Oculaires Liées à l'Age" (POLA) Study, a population-based prospective cohort study.
METHODS: Retinal photographs were graded according to the international classification. Early age-related maculopathy (ARM) was defined by the presence of (1) soft indistinct drusen (>125 microm) and/or (2) soft distinct drusen (>125 microm) associated with pigmentary abnormalities.
RESULTS: The 3-year incidence of AMD was 0.49% (95% confidence interval [CI]: 0.13 to 0.85) and increased significantly with age, reaching 3.41% (95% CI: 0 to 7.2) in participants aged 80 years or more. After adjustment for age, eyes with early ARM at baseline were 78 times more at risk of developing AMD than eyes without early ARM (OR = 78.4, 95% CI: 14.6 to 420.1).
CONCLUSIONS: This study confirms that AMD develops mainly in subjects aged 80 years or older, and in subjects with early ARM.

Entities:  

Mesh:

Year:  2005        PMID: 16310477     DOI: 10.1016/j.ajo.2005.05.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.

Authors:  Valentine Saunier; Bénédicte M J Merle; Marie-Noëlle Delyfer; Audrey Cougnard-Grégoire; Marie-Bénédicte Rougier; Philippe Amouyel; Jean-Charles Lambert; Jean-François Dartigues; Jean-François Korobelnik; Cécile Delcourt
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

2.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

3.  Combination therapy for choroidal neovascularisation.

Authors:  Albert J Augustin; Indre Offermann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study.

Authors:  Andrew Bastawrous; Wanjiku Mathenge; Tunde Peto; Nisha Shah; Kevin Wing; Hillary Rono; Helen A Weiss; David Macleod; Allen Foster; Matthew Burton; Hannah Kuper
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

5.  Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018: The LANDSCAPE Study.

Authors:  Catherine P Creuzot-Garcher; Mayer Srour; Florian Baudin; Vincent Daien; Corinne Dot; Sylvia Nghiem-Buffet; Jean-Francois Girmens; Nicolas Coulombel; Anne Ponthieux; Cecile Delcourt
Journal:  Ophthalmol Sci       Date:  2022-01-22

6.  Incidence, progression and risk factors of age-related macular degeneration in 35-95-year-old individuals from three jointly designed German cohort studies.

Authors:  Caroline Brandl; Felix Günther; Martina E Zimmermann; Kathrin I Hartmann; Gregor Eberlein; Teresa Barth; Thomas W Winkler; Birgit Linkohr; Margit Heier; Annette Peters; Jeany Q Li; Robert P Finger; Horst Helbig; Bernhard H F Weber; Helmut Küchenhoff; Arthur Mueller; Klaus J Stark; Iris M Heid
Journal:  BMJ Open Ophthalmol       Date:  2022-01-04

7.  Five-year cumulative incidence and progression of age-related macular degeneration: results from the German population-based Gutenberg Health Study (GHS).

Authors:  Christina A Korb; Hisham Elbaz; Alexander K Schuster; Stefan Nickels; Katharina A Ponto; Andreas Schulz; Philipp S Wild; Thomas Münzel; Manfred E Beutel; Irene Schmidtmann; Karl J Lackner; Tunde Peto; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-23       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.